Advertisement
News
Subscribe to MDT Magazine News

SCAI Announces National Quality Program to Improve Cardiovascular Patient Care

May 5, 2011 11:33 am | by Bio-Medicine.Org | Comments

BALTIMORE, May 5, 2011 /- Today at the Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions, SCAI announced its national quality improvement program to measure and improve quality in the cath lab for better patient care. Building on its legacy of using...

TOPICS:

Providing More Detailed Diagnosis in Less Time

May 5, 2011 11:32 am | by Bio-Medicine.Org | Comments

SHENZHEN, China, May 5, 2011 /PRNewswire-Asia/ -- People have become more and more intent on enjoying convenience at communal facilities and getting more services in food, clothing, housing, and transport. However, it is still very difficult for sick people to get timely and easy...

TOPICS:

Kendle to sell company for $232M to INC Research

May 5, 2011 10:45 am | by The Associated Press | Comments

Contract research organization INC Research LLC will buy rival Kendle International Inc. for $232 million in cash, the companies said on Thursday, creating a larger company focusing on drug development services.INC, which is based in Raleigh, N.C. and privately held by Avista Capital Partners...

Advertisement

Innovatient connects with $1M funding round

May 5, 2011 10:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Innovatient Solutions Inc., a health information startup in Farmington, Conn., has raised $1 million in a funding round led by a $500,000 financing from Connecticut Innovations.

Spring Bank Pharma wins $3.9M NIH grant to fight Hep B

May 5, 2011 10:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Milford company Spring Bank Pharmaceuticals Inc. has landed a $3.9 million grant from the National Institutes of Health to further develop a drug candidate to treat Hepatitis B infections.

Summary Box: CVS Caremark 1Q profit declines

May 5, 2011 9:45 am | by The Associated Press | Comments

DOWN QUARTER: CVS Caremark Corp. said its net income slipped in the first quarter as profits shrank at its Caremark pharmacy benefits management business.CONTRACT COSTS: The company announced in February that Caremark's profit would fall in 2011 — its second consecutive year of declining income —...

On the Call: CVS Caremark CEO Larry Merlo

May 5, 2011 9:45 am | by The Associated Press | Comments

Caremark, the pharmacy benefits management business of CVS Caremark Corp., has struggled and reported lower profits in recent years.Caremark lost several large contracts in 2010, and this year, the company is expected to report a smaller profit because of expenses related to a huge new contract...

Misonix Schedules Third Quarter 2011 Financial Results Conference Call; May 10, 2011 at 11:30 A.M. Eastern

May 5, 2011 9:34 am | by Bio-Medicine.Org | Comments

FARMINGDALE, N.Y., May 5, 2011 /- Misonix, Inc. (NASDAQ: MSON ), a medical device company that designs, manufactures, and markets innovative therapeutic ultrasonic products worldwide for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and...

TOPICS:
Advertisement

OTC Industry Announces Voluntary Transition to One Concentration of Single-Ingredient Pediatric Liquid Acetaminophen Medicines

May 5, 2011 9:34 am | by Bio-Medicine.Org | Comments

WASHINGTON, May 5, 2011 /PRNewswire-USNewswire/ -- Today, the Consumer Healthcare Products Association (CHPA), representing the makers of over-the-counter (OTC) single-ingredient liquid pediatric acetaminophen medicines, announces plans to convert these pediatric products to just one...

TOPICS:

CardioMEMS Founder Dr. Jay Yadav Chosen as Health-Care Heroes Finalist by Atlanta Business Chronicle

May 5, 2011 9:34 am | by Bio-Medicine.Org | Comments

ATLANTA, May 5, 2011 /- CardioMEMS, Inc ., an Atlanta-based medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, today announced that its founder and CEO Jay Yadav, M.D., has been chosen as a...

TOPICS:

Spring Bank Pharmaceuticals Awarded $3.9 Million RO1 NIH Grant to Advance Innovative Hepatitis Program

May 5, 2011 9:34 am | by Bio-Medicine.Org | Comments

MILFORD, Mass., May 5, 2011 /- Spring Bank Pharmaceuticals today announced it has been awarded an RO1 grant from the National Institute of Health, National Institute of Allergy and Infectious Diseases for the development of SB 9200, a novel, orally bioavailable agent for the treatment of...

TOPICS:

American Pacific to Release Financial Results and Hold Fiscal 2011 Second Quarter Investor Teleconference

May 5, 2011 9:33 am | by Bio-Medicine.Org | Comments

LAS VEGAS, May 5, 2011 /- American Pacific Corporation (Nasdaq: APFC) ("AMPAC") announced today that it will release its Fiscal 2011 second quarter financial results on Thursday, May 12, 2011, immediately after the market closes. Joseph Carleone, President and Chief Executive Officer and...

TOPICS:

InspireMD to Commence Trading as a Public Company Under Ticker Symbol "NSPR"

May 5, 2011 9:33 am | by Bio-Medicine.Org | Comments

TEL AVIV, Israel, May 5, 2011 /- InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard™ mesh protective stent system, announced today that it has been approved by FINRA to have its stock quoted on the Over-the-Counter Bulletin Board (OTCBB) under...

TOPICS:

ALTITUDE Clinical Data Show ICD Therapy Saves Lives Without Mortality Increase from Device Shock

May 5, 2011 9:33 am | by Boston Scientific | Comments

NATICK, Mass. and SAN FRANCISCO, May 5, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of its ALTITUDE® Clinical Science program, which demonstrated that def

TOPICS:

New Data Provide First Look at Ability to Detect Life-Threatening Heart Problems in Some High-Risk Patients

May 5, 2011 8:32 am | by Bio-Medicine.Org | Comments

BALTIMORE, May 5, 2011 /- New data presented today at the Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions are the first to look at the use of highly specialized signals within implantable cardioverter defibrillators (ICDs) to detect restricted blood...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading